A Multi-Centre Clinical Study in Chronic Spinal Cord Injury Patients

July 2, 2009 updated by: China Spinal Cord Injury Network
To establish a solid foundation, e.g. network and a coordinating centre for testing new SCI therapies in forthcoming randomized controlled multi-centre clinical trials following international standards and guidelines

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China
        • 301 Orthopedic Hospital
      • Chongqing, China
        • Second Affiliated Hospital of Third Military Medcial University
    • Fujian
      • Fuzhou, Fujian, China
        • First Affiliated Hospital of Fujian Medical University
      • Hualien, Taiwan
        • Buddhist Tzu Chi General Hospital
      • Taichung, Taiwan
        • China Medical University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Hospital

Description

Inclusion Criteria:

  1. Male or female adult subjects, 18 to 60 years of age;
  2. Have a clinical diagnosis of chronic SCI (defined as a history of ≥ 12 months suffering SCI);
  3. The diagnosis of SCI was confirmed by MRI; and
  4. Voluntarily signs and dates an Informed Consent Form, approved by an Institutional Review Board (IRB)/Independent Ethics Committee (IEC), prior to any study-specific procedures

Exclusion Criteria:

  1. Severe head injury;
  2. Is medically or mentally unstable according to the judgement of the Investigator;
  3. History of Multiple Sclerosis or peripheral demyelinating disease;
  4. Likely to have experimental therapy;
  5. Any criteria, which, in the opinion of the investigator, suggests that the subject would not be compliant with the study protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The primary study outcomes will be the subject recruitment rate, the subject drip out rate, the number of missing values and the number of submitted incorrect values
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Wise Young, MD, PhD, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2007

Primary Completion (Actual)

December 1, 2008

Study Completion (Actual)

March 1, 2009

Study Registration Dates

First Submitted

January 2, 2008

First Submitted That Met QC Criteria

January 2, 2008

First Posted (Estimate)

January 14, 2008

Study Record Updates

Last Update Posted (Estimate)

July 3, 2009

Last Update Submitted That Met QC Criteria

July 2, 2009

Last Verified

July 1, 2009

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

3
Subscribe